Clin2
NCT07641361Possibly a fitRecruiting

Staying Hydrated to Feel Better on GLP-1 Medication

Obesity & OverweightType 2 DiabetesType 2 Diabetes (Adult Onset)Obesity Type 2 Diabetes MellitusDehydration

Part of Hormones & metabolism clinical trials.

This study tests whether drinking more water helps reduce uncomfortable side effects (like nausea and vomiting) when you first start taking GLP-1 medications for weight loss or diabetes. You'll be asked to follow a hydration plan and report how you feel.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old
  • You started a GLP-1 medication (like Ozempic, Wegovy, or Mounjaro) within the last week
  • You speak and read English fluently
  • You can commit to completing the full study and following the hydration plan
  • You are not pregnant and do not plan to become pregnant during the study
  • You do not have a pacemaker or other cardiac implant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07770906Not yet recruiting
Effect of GLP-1 receptor agonists on gum disease treatment

This study looks at how GLP-1 receptor agonists (medicines for diabetes or weight loss) affect the results of non-surgical gum disease treatment in adults with overweight and periodontitis. If you are 18-65, have a BMI of 25 or higher, have gum disease, and have at least 20 teeth, you may be eligible. Participants will either continue their usual care or take a GLP-1 medicine, and then receive standard gum treatment.

NCT07743567Recruiting
Weight and pregnancy outcomes after GLP-1 use

This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.

Kansas City, Kansas
NCT06843512Recruiting
How GLP-1 meds change eating habits

This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.

State College, Pennsylvania
NCT07089732Not yet recruiting
GLP-1 drink for blood sugar and gut health in prediabetes

This trial tests whether a special GLP-1 formula drink can help control blood sugar and improve gut bacteria in people with prediabetes. It may offer a new way to manage early diabetes risk.

Taichung, South
NCT07270497Recruiting
New weight-loss medicines and diet changes in people with excess weight

This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.

Warsaw, Warszawa
NCT07213323Recruiting
Probiotics for Digestion During Weight-Loss Treatment

This study tests whether taking a probiotic (a type of 'good' bacteria) can improve digestion and gut health in people who are starting a GLP-1 RA medicine for weight loss. You would take the probiotic daily and answer questions about your digestive symptoms.

Pierre-Bénite

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.